With the recent bank failures affecting many life sciences companies, it can be easy to lose sight of all the other industry news this week. So we will focus on the other stories you may have missed. In this issue we look at an increase in Nasdaq delisting notices among biotech companies, a major ... READ MORE >
Health Care
From hospital systems to home care providers, the health care sector is replete with middle market companies. The health needs of an aging population assure that this industry will continue to grow in coming years.
ChatGPT could help overburdened physicians, but careful evaluation is needed
Health care’s post-pandemic lurch into the virtual world has challenged physicians to continuously communicate with their patients as they provide ongoing care. However, as the patient-doctor relationship has evolved, physicians have found themselves responding to sometimes thousands of patient messages ... READ MORE >
5 things to know in life sciences: Week of March 6, 2023
This week we look at manufacturing investments taking place in life sciences, the Food and Drug Administration’s first Safer Technologies Program approval as well as the agency’s first full approval of a COVID-19 rapid antigen test. Finally, we highlight a story on the thriving canine population of ... READ MORE >
5 things to know in life sciences: Week of Feb. 27, 2023
This week we look at an artificial intelligence-powered platform that can detect early signs of heart disease, the Food and Drug Administration's treatment clearance that could help prevent migraine symptoms, and a revolutionary genomic medicine startup that raised $135 million. We also highlight ... READ MORE >
5 things to know in life sciences: Week of Feb. 20, 2023
This week we look at a new feature on the Apple Watch that could benefit diabetes patients, a newly approved hemophilia drug and calls for a new regulatory process for artificial intelligence-based medical technology. We also continue to explore concerns about clinical trial diversity. Finally, we ... READ MORE >
5 things to know in life sciences: Week of Feb. 13, 2023
This week we look at the Food and Drug Administration’s approval of an over-the-counter naloxone nasal spray, promising vaccines nearing approval to treat respiratory syncytial virus, and the FDA’s new guidance on diversity considerations for later-stage clinical trials. We also look at a new ... READ MORE >
5 things to know in life sciences: Week of Feb. 6, 2023
This week we look at the President’s State of the Union Address and his support to reduce drug prices, a concerning drug shortage in European countries, and a new brain-computer interface company that raised $41 million. We also review the recent acquisition of Cardiovascular Systems by Abbott. Finally, ... READ MORE >
5 things to know in life sciences: Week of Jan. 30, 2023
This week we look at how start-ups are rethinking how clinical trials are designed and managed to improve efficiency and accuracy. We also examine biosimilar versions of a blockbuster biologic, what to expect for cell and gene therapy companies, and why the U.S. government may pay lower prices after ... READ MORE >
5 things to know in life sciences: Week of Jan. 23, 2023
This week we look at an emerging funding source within biotechs, the hottest topics during the recent JP Morgan Healthcare Conference, a revolutionary app to automate insulin dosing, the struggle for Medicare reimbursement of obesity drugs, and the Food and Drug Administration’s final guidance on ... READ MORE >
5 things to know in life sciences: Week of Jan. 16, 2023
This week we look at growing pharmaceutical manufacturing investment, the potential for a biotech recovery in 2023, discussion about the future home of the JP Morgan Healthcare Conference, U.S. biopharma wins in the Chinese market, and the future of the Johnson & Johnson COVID-19 vaccine. Each week ... READ MORE >